Projects funded by the NCN
A new concept of inhibiting the progression of Alzheimer's disease based on the modification of the blood-brain barrier (BBB) properties by pro-resolving compounds.
2024/55/B/NZ4/01732
Keywords:
blood-brain barrier BMEC astrocytes BBB models Alzheimer's disease FPR2 receptor and its ligands immuno-activation
Descriptors:
- NZ4_07:
- NZ7_14:
- NZ3_06:
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 28 - announced on 2024-09-16
Amount awarded: 2 997 400 PLN
Project start date (Y-m-d): 2025-11-26
Project end date (Y-m-d): 2029-11-25
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.